306 related articles for article (PubMed ID: 17182012)
1. Immunohistochemical localization of dopamine receptor subtypes (D1R-D5R) in Alzheimer's disease brain.
Kumar U; Patel SC
Brain Res; 2007 Feb; 1131(1):187-96. PubMed ID: 17182012
[TBL] [Abstract][Full Text] [Related]
2. Colocalization of dopamine receptor subtypes with dopamine and cAMP-regulated phosphoprotein (DARPP-32) in rat brain.
Rajput PS; Kharmate G; Somvanshi RK; Kumar U
Neurosci Res; 2009 Sep; 65(1):53-63. PubMed ID: 19465068
[TBL] [Abstract][Full Text] [Related]
3. Expression of somatostatin and somatostatin receptor subtypes in Apolipoprotein D (ApoD) knockout mouse brain: An immunohistochemical analysis.
Rajput PS; Billova S; Patel SC; Kharmate G; Somvanshi RK; Kumar U
J Chem Neuroanat; 2009 Sep; 38(1):20-33. PubMed ID: 19465111
[TBL] [Abstract][Full Text] [Related]
4. Differences in regional and subcellular localization of G(q/11) and RGS4 protein levels in Alzheimer's disease: correlation with muscarinic M1 receptor binding parameters.
Muma NA; Mariyappa R; Williams K; Lee JM
Synapse; 2003 Jan; 47(1):58-65. PubMed ID: 12422374
[TBL] [Abstract][Full Text] [Related]
5. Cellular distribution of insulin-like growth factor-II/mannose-6-phosphate receptor in normal human brain and its alteration in Alzheimer's disease pathology.
Kar S; Poirier J; Guevara J; Dea D; Hawkes C; Robitaille Y; Quirion R
Neurobiol Aging; 2006 Feb; 27(2):199-210. PubMed ID: 16399207
[TBL] [Abstract][Full Text] [Related]
6. Functional analysis of human D1 and D5 dopaminergic G protein-coupled receptors: lessons from mutagenesis of a conserved serine residue in the cytosolic end of transmembrane region 6.
Plouffe B; Tiberi M
Methods Mol Biol; 2013; 964():141-80. PubMed ID: 23296783
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor-I and its receptor in the frontal cortex, hippocampus, and cerebellum of normal human and alzheimer disease brains.
Jafferali S; Dumont Y; Sotty F; Robitaille Y; Quirion R; Kar S
Synapse; 2000 Dec; 38(4):450-9. PubMed ID: 11044892
[TBL] [Abstract][Full Text] [Related]
8. [Dopamine receptor knockout mice].
Aiba A
Nihon Shinkei Seishin Yakurigaku Zasshi; 1999 Dec; 19(5):251-5. PubMed ID: 10803208
[TBL] [Abstract][Full Text] [Related]
9. Autoradiographic distribution of M1, M2, M3, and M4 muscarinic receptor subtypes in Alzheimer's disease.
Rodríguez-Puertas R; Pascual J; Vilaró T; Pazos A
Synapse; 1997 Aug; 26(4):341-50. PubMed ID: 9215593
[TBL] [Abstract][Full Text] [Related]
10. Altered NCAM expression associated with the cholinergic system in Alzheimer's disease.
Aisa B; Gil-Bea FJ; Solas M; García-Alloza M; Chen CP; Lai MK; Francis PT; Ramírez MJ
J Alzheimers Dis; 2010; 20(2):659-68. PubMed ID: 20164549
[TBL] [Abstract][Full Text] [Related]
11. Differential damage in the frontal cortex with aging, sporadic and familial Alzheimer's disease.
Leuba G; Vernay A; Zimmermann V; Saini K; Kraftsik R; Savioz A
Brain Res Bull; 2009 Oct; 80(4-5):196-202. PubMed ID: 19559767
[TBL] [Abstract][Full Text] [Related]
12. Impaired metabotropic glutamate receptor/phospholipase C signaling pathway in the cerebral cortex in Alzheimer's disease and dementia with Lewy bodies correlates with stage of Alzheimer's-disease-related changes.
Albasanz JL; Dalfó E; Ferrer I; Martín M
Neurobiol Dis; 2005 Dec; 20(3):685-93. PubMed ID: 15949941
[TBL] [Abstract][Full Text] [Related]
13. Neurotransmitter changes in Alzheimer's disease: implications to diagnostics and therapy.
Reinikainen KJ; Soininen H; Riekkinen PJ
J Neurosci Res; 1990 Dec; 27(4):576-86. PubMed ID: 1981917
[TBL] [Abstract][Full Text] [Related]
14. Expression of cellular prion protein in the frontal and occipital lobe in Alzheimer's disease, diffuse Lewy body disease, and in normal brain: an immunohistochemical study.
Rezaie P; Pontikis CC; Hudson L; Cairns NJ; Lantos PL
J Histochem Cytochem; 2005 Aug; 53(8):929-40. PubMed ID: 16055747
[TBL] [Abstract][Full Text] [Related]
15. Dopamine D5 receptor localization on cholinergic neurons of the rat forebrain and diencephalon: a potential neuroanatomical substrate involved in mediating dopaminergic influences on acetylcholine release.
Berlanga ML; Simpson TK; Alcantara AA
J Comp Neurol; 2005 Nov; 492(1):34-49. PubMed ID: 16175554
[TBL] [Abstract][Full Text] [Related]
16. Impaired coupling of muscarinic M1 receptors to G-proteins in the neocortex is associated with severity of dementia in Alzheimer's disease.
Tsang SW; Lai MK; Kirvell S; Francis PT; Esiri MM; Hope T; Chen CP; Wong PT
Neurobiol Aging; 2006 Sep; 27(9):1216-23. PubMed ID: 16129514
[TBL] [Abstract][Full Text] [Related]
17. Reduction of renal dopamine receptor expression in obese Zucker rats: role of sex and angiotensin II.
Wang X; Li F; Jose PA; Ecelbarger CM
Am J Physiol Renal Physiol; 2010 Nov; 299(5):F1164-70. PubMed ID: 20810614
[TBL] [Abstract][Full Text] [Related]
18. Alterations in adrenergic receptors of frontal cortex and cerebral microvessels in Alzheimer's disease and aging.
Kalaria RN; Andorn AC; Harik SI
Prog Clin Biol Res; 1989; 317():367-74. PubMed ID: 2557637
[TBL] [Abstract][Full Text] [Related]
19. Dopamine receptor dysregulation in hippocampus of aged rats underlies chronic pulsatile L-Dopa treatment induced cognitive and emotional alterations.
Hernández VS; Luquín S; Jáuregui-Huerta F; Corona-Morales AA; Medina MP; Ruíz-Velasco S; Zhang L
Neuropharmacology; 2014 Jul; 82():88-100. PubMed ID: 24291463
[TBL] [Abstract][Full Text] [Related]
20. Dopamine by itself activates either D2, D3 or D1/D5 dopaminergic receptors in normal human T-cells and triggers the selective secretion of either IL-10, TNFalpha or both.
Besser MJ; Ganor Y; Levite M
J Neuroimmunol; 2005 Dec; 169(1-2):161-71. PubMed ID: 16150496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
